Chemotherapy ends, nerve pain can persist

Published Catarina de Freitas on

MondayLunchLive

Cancer care should not stop at survival. Many cancer survivors live with chemotherapy-induced peripheral neuropathy (CIPN), a persistent and often debilitating side effect that can cause ongoing pain, tingling and numbness, affecting mobility, independence and everyday life. Yet effective treatment options remain limited.

Could a non-drug treatment offer another way forward?

The TMaC Study investigated repetitive transcranial magnetic stimulation (rTMS) as a non-invasive approach to managing chronic CIPN in bowel cancer survivors. This session will share findings from the randomised, sham-controlled study, alongside participants' experiences of living with neuropathy and receiving TMS.

Watch on demand

Session recording

At a glance

The session in brief

Originally held

Monday 19 October 2026

Online.

Who this is for

Cancer survivors, patients and carers, cancer researchers, oncology and supportive care professionals, allied health professionals, students

Anyone interested in cancer survivorship and supportive care.

Contributors

Chair and speakers

Portrait of Dr Victoria Choi

Chair

Dr Victoria Choi

Research Fellow, Senior Acupuncturist, Chris O'Brien Lifehouse; Senior Clinical Lecturer, University of Sydney

Dr Choi's clinical and research work focuses on integrative oncology and supportive cancer care, with particular interests in the use of acupuncture to manage cancer-related symptoms and treatment-related adverse effects. Her research spans clinical and mechanistic research in acupuncture, as well as health services research. Dr Choi is Principal Investigator of a clinical trial investigating electroacupuncture for chemotherapy-induced peripheral neuropathy (CIPN) in women being treated for breast cancer.

Portrait of Eva Kate Moore

Speaker

Eva Kate Moore

PhD Candidate / Neuroscience and Supportive Care Researcher, School of Pharmacy and Biomedical Science, Adelaide University

Eva Moore is a PhD candidate and neuroscience researcher whose work focuses on understanding how the nervous system functions, adapts and can be modulated to improve health outcomes. Her research interests span neurophysiology, neuroplasticity, ageing, pain and non-invasive brain stimulation.

Eva leads the TMaC Study, a clinical trial investigating repetitive transcranial magnetic stimulation for persistent chemotherapy-induced peripheral neuropathic pain in bowel cancer survivors. Her work aims to translate neuroscience into meaningful improvements in supportive care and quality of life for people affected by cancer.

Resource details

hands holding fairy lights
Course type
Webinars
Duration
60 mins
Price
$0.00
Curriculum Area
Treatment (incl. Supportive Care)
Monitoring and Surveillance
Research (incl. Clinical Trials)
Clinical Care
Speciality
Allied Health professional
Clinical trials
Clinician
Consumer / patient / carer
Early to mid career researcher
GP
Nurse
Senior researcher / scientist
Student/trainee
Central nervous system
Clinical care
Monday Lunch Live
Research
Survivorship

This course is brought to you by

Alliance members